Magneto-asteroseismology of massive magnetic pulsators

Simultaneously and coherently studying the large-scale magnetic field and the stellar pulsations of a massive star provides strong complementary diagnostics suitable for detailed stellar modelling. This hybrid method is called magneto-asteroseismology and permits the determination of the internal structure and conditions within magnetic massive pulsators, for example the effect of magnetism on non-standard mixing processes. Here, we overview this technique, its requirements, and list the currently known suitable stars to apply the method.Comment: 5 pages, 1 table, IAUS 329 conference proceeding

Testing the asymptotic relation for period spacings from mixed modes of red giants observed with the Kepler mission

Dipole mixed pulsation modes of consecutive radial order have been detected for thousands of low-mass red-giant stars with the NASA space telescope Kepler. Such modes have the potential to reveal information on the physics of the deep stellar interior. Different methods have been proposed to derive an observed value for the gravity-mode period spacing, the most prominent one relying on a relation derived from asymptotic pulsation theory applied to the gravity-mode character of the mixed modes. Our aim is to compare results based on this asymptotic relation with those derived from an empirical approach for three pulsating red-giant stars. We developed a data-driven method to perform frequency extraction and mode identification. Next, we used the identified dipole mixed modes to determine the gravity-mode period spacing by means of an empirical method and by means of the asymptotic relation. In our methodology, we consider the phase offset, $\epsilon_{\mathrm{g}}$, of the asymptotic relation as a free parameter. Using the frequencies of the identified dipole mixed modes for each star in the sample, we derived a value for the gravity-mode period spacing using the two different methods. These differ by less than 5%. The average precision we achieved for the period spacing derived from the asymptotic relation is better than 1%, while that of our data-driven approach is 3%. Good agreement is found between values for the period spacing derived from the asymptotic relation and from the empirical method. Full abstract in PDF file.Comment: 14 pages, 13 figures, accepted for publication in A&

Studying the photometric and spectroscopic variability of the magnetic hot supergiant ζ\zeta Orionis Aa

Massive stars play a significant role in the chemical and dynamical evolution of galaxies. However, much of their variability, particularly during their evolved supergiant stage, is poorly understood. To understand the variability of evolved massive stars in more detail, we present a study of the O9.2Ib supergiant $\zeta$ Ori Aa, the only currently confirmed supergiant to host a magnetic field. We have obtained two-color space-based BRIght Target Explorer photometry (BRITE) for $\zeta$ Ori Aa during two observing campaigns, as well as simultaneous ground-based, high-resolution optical CHIRON spectroscopy. We perform a detailed frequency analysis to detect and characterize the star's periodic variability. We detect two significant, independent frequencies, their higher harmonics, and combination frequencies: the stellar rotation period $P_{\mathrm{rot}} = 6.82\pm0.18$ d, most likely related to the presence of the stable magnetic poles, and a variation with a period of $10.0\pm0.3$ d attributed to circumstellar environment, also detected in the H$\alpha$ and several He I lines, yet absent in the purely photospheric lines. We confirm the variability with $P_{\mathrm{rot}}$/4, likely caused by surface inhomogeneities, being the possible photospheric drivers of the discrete absorption components. No stellar pulsations were detected in the data. The level of circumstellar activity clearly differs between the two BRITE observing campaigns. We demonstrate that $\zeta$ Ori Aa is a highly variable star with both periodic and non-periodic variations, as well as episodic events. The rotation period we determined agrees well with the spectropolarimetric value from the literature. The changing activity level observed with BRITE could explain why the rotational modulation of the magnetic measurements was not clearly detected at all epochs.Comment: 20 pages, 5 tables, 12 figures, accepted for publication in A&

New β Cep pulsators discovered with K2 space photometry

Contains fulltext : 207549.pdf (publisher's version ) (Open Access

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation

BACKGROUND The effect of single as compared with dual antiplatelet treatment on bleeding and thromboembolic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indication for long-term anticoagulation has not been well studied. METHODS In a randomized, controlled trial, we assigned a subgroup of patients who were undergoing TAVI and did not have an indication for long-term anticoagulation, in a 1:1 ratio, to receive aspirin alone or aspirin plus clopidogrel for 3 months. The two primary outcomes were all bleeding (including minor, major, and life-threatening or disabling bleeding) and non-procedure-related bleeding over a period of 12 months. Most bleeding at the TAVI puncture site was counted as non-procedure-related. The two secondary outcomes were a composite of death from cardiovascular causes, non-procedure-related bleeding, stroke, or myocardial infarction (secondary composite 1) and a composite of death from cardiovascular causes, ischemic stroke, or myocardial infarction (secondary composite 2) at 1 year, with both outcomes tested sequentially for noninferiority (noninferiority margin, 7.5 percentage points) and superiority. RESULTS A total of 331 patients were assigned to receive aspirin alone and 334 were assigned to receive aspirin plus clopidogrel. A bleeding event occurred in 50 patients (15.1%) receiving aspirin alone and in 89 (26.6%) receiving aspirin plus clopidogrel (risk ratio, 0.57; 95% confidence interval [CI], 0.42 to 0.77; P=0.001). Non-procedure-related bleeding occurred in 50 patients (15.1%) and 83 patients (24.9%), respectively (risk ratio, 0.61; 95% CI, 0.44 to 0.83; P=0.005). A secondary composite 1 event occurred in 76 patients (23.0%) receiving aspirin alone and in 104 (31.1%) receiving aspirin plus clopidogrel (difference, −8.2 percentage points; 95% CI for noninferiority, −14.9 to −1.5; P<0.001; risk ratio, 0.74; 95% CI for superiority, 0.57 to 0.95; P=0.04). A secondary composite 2 event occurred in 32 patients (9.7%) and 33 patients (9.9%), respectively (difference, −0.2 percentage points; 95% CI for noninferiority, −4.7 to 4.3; P=0.004; risk ratio, 0.98; 95% CI for superiority, 0.62 to 1.55; P=0.93). A total of 44 patients (13.3%) and 32 (9.6%), respectively, received oral anticoagulation during the trial. CONCLUSIONS Among patients undergoing TAVI who did not have an indication for oral anticoagulation, the incidence of bleeding and the composite of bleeding or thromboembolic events at 1 year were significantly less frequent with aspirin than with aspirin plus clopidogrel administered for 3 months

A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA

INTRODUCTION: Increased expression of IL-33 and its receptor ST2, encoded by the IL1RL1 gene, has been detected in the inflamed arteries of giant cell arteritis (GCA) patients. The aim of the present study was to investigate for the first time the potential influence of the IL33 and IL1RL1 loci on GCA predisposition. METHODS: A total of 1,363 biopsy-proven GCA patients and 3,908 healthy controls from four European cohorts (Spain, Italy, Germany and Norway) were combined in a meta-analysis. Six genetic variants: rs3939286, rs7025417 and rs7044343, within the IL33 gene, and rs2058660, rs2310173 and rs13015714, within the IL1RL1 gene, previously associated with immune-related diseases, were genotyped using predesigned TaqMan assays. RESULTS: A consistent association between the rs7025417 polymorphism and GCA was evident in the overall meta-analysis, under both allele (P(MH) = 0.041, OR = 0.88, CI 95% 0.78-0.99) and recessive (P(MH) = 3.40E-03, OR = 0.53, CI 95% 0.35-0.80) models. No statistically significant differences between allele or genotype frequencies for the other IL33 and IL1RL1 genetic variants were detected in this pooled analysis. CONCLUSIONS: Our results clearly evidenced the implication of the IL33 rs7025417 polymorphism in the genetic network underlying GCA

Streptozotocin, Type I Diabetes Severity and Bone

As many as 50% of adults with type I (T1) diabetes exhibit bone loss and are at increased risk for fractures. Therapeutic development to prevent bone loss and/or restore lost bone in T1 diabetic patients requires knowledge of the molecular mechanisms accounting for the bone pathology. Because cell culture models alone cannot fully address the systemic/metabolic complexity of T1 diabetes, animal models are critical. A variety of models exist including spontaneous and pharmacologically induced T1 diabetic rodents. In this paper, we discuss the streptozotocin (STZ)-induced T1 diabetic mouse model and examine dose-dependent effects on disease severity and bone. Five daily injections of either 40 or 60 mg/kg STZ induce bone pathologies similar to spontaneously diabetic mouse and rat models and to human T1 diabetic bone pathology. Specifically, bone volume, mineral apposition rate, and osteocalcin serum and tibia messenger RNA levels are decreased. In contrast, bone marrow adiposity and aP2 expression are increased with either dose. However, high-dose STZ caused a more rapid elevation of blood glucose levels and a greater magnitude of change in body mass, fat pad mass, and bone gene expression (osteocalcin, aP2). An increase in cathepsin K and in the ratio of RANKL/OPG was noted in high-dose STZ mice, suggesting the possibility that severe diabetes could increase osteoclast activity, something not seen with lower doses. This may contribute to some of the disparity between existing studies regarding the role of osteoclasts in diabetic bone pathology. Examination of kidney and liver toxicity indicate that the high STZ dose causes some liver inflammation. In summary, the multiple low-dose STZ mouse model exhibits a similar bone phenotype to spontaneous models, has low toxicity, and serves as a useful tool for examining mechanisms of T1 diabetic bone loss

MELCHIORS: The Mercator Library of High Resolution Stellar Spectroscopy

Aims. Over the past decades, libraries of stellar spectra have been used in a large variety of science cases, including as sources of reference spectra for a given object or a given spectral type. Despite the existence of large libraries and the increasing number of projects of large-scale spectral surveys, there is to date only one very high-resolution spectral library offering spectra from a few hundred objects from the southern hemisphere (UVES-POP). We aim to extend the sample, offering a finer coverage of effective temperatures and surface gravity with a uniform collection of spectra obtained in the northern hemisphere.Methods. Between 2010 and 2020, we acquired several thousand echelle spectra of bright stars with the Mercator-HERMES spectrograph located in the Roque de Los Muchachos Observatory in La Palma, whose pipeline offers high-quality data reduction products. We have also developed methods to correct for the instrumental response in order to approach the true shape of the spectral continuum. Additionally, we have devised a normalisation process to provide a homogeneous normalisation of the full spectral range for most of the objects.Results. We present a new spectral library consisting of 3256 spectra covering 2043 stars. It combines high signal-to-noise and high spectral resolution over the entire range of effective temperatures and luminosity classes. The spectra are presented in four versions: raw, corrected from the instrumental response, with and without correction from the atmospheric molecular absorption, and normalised (including the telluric correction)